Skip to main content
. 2010 Oct 7;10(8):796–810. doi: 10.4161/cbt.10.8.12914

Table 3.

Partial list of overexpressed proteins that were previously reported in esophageal squamous cell carcinoma

Gene symbol Protein Features Citation Fold change upregulation in this study
Spectrum mill Mascot distiller
1. HSPA1A Heat shock 70 KD protein 1A HSP72 overexpression was observed in ESCC tumors with low differentiation. It is known to be involved in oncogenic transformation of epithelial carcinomas. Hoshino et al. (2007)90 19.3 Not detected in Normal
2. CALR Calreticulin Endoplasmic reticulum protein reported to be overexpressed in 66% of ESCC cases. Du et al. (2007)20 6.9 3.4
3. MMP13 Matrix metallopeptidase 13 (collagenase) MMP13 upregulation and overexpression has been reported earlier in ESCC. It is an independent and negative indicator of prognosis for ESCC. Gu et al. (2005);91 Kashyap et al. (2009)41 Not detectable in normal 14.2
4. LCN2 Lipocalin 2 Extracellular protein involved in cell-cell adhesion. Zhang et al. (2007)50 Not detectable in normal 2.9
5. TFRC Transferrin receptor Transmembrane protein involved in iron transport and cellular homeostastsis. Reported as prognostic marker for distant metastasis in ESCC. Wada et al. (2006)42 4.3 3.6
6. TGFBI Transforming growth factor beta induced 68 kda Extracellular protein involved in signal transduction. Reported to be a marker for tumor metastasis in ESCC patients. Wong et al. (2009)72 9.4 6.1
7. VCP Valosin-containing protein ATP binding protein involved in vesicular transport. Reported as prognostic marker for disease free survival in ESCC patients. Yamamoto et al. (2004)92 6.7 3.4
8. MMP1 Matrix metallopeptidase 13 or collagenase It is an interstitial collagenase. MMP1 upregulation and overexpression was observed in ESCC. Kashyap et al. (2009)41 23.8 7.7
9. THBS1 Thrombospondin 1 Extracellular matrix protein involved in cellcell adhesion. Reported to be upregulated in ESCC. Kashyap et al. (2009)41 2.3 5.3
10. HSP90AA1 Heat shock protein 90 kDa alpha (cytosolic), class A member 1 HSP90 overexpression has been reported in esophageal cancers and the preclinical studies and its report in different biological fluids make indicates HSP90 as a promising therapeutic target for ESCC. Wu et al. (2009)93 3.9 -